Alentis Therapeutics AG
Alentis Therapeutics AG is a Swiss Biotech company based in Basel (Basel-Stadt). It holds no Swissmedic authorisations for human medicines of its own and is listed here as a Biotech.
Key facts
| Sector | Biotech |
|---|---|
| City | Basel |
| Canton | Basel-Stadt |
| Authorisation holder | No |
| Medicines | Not available |
| Founded | 2019 |
| Employees | 11-50 |
| Parent group | Not available |
| Activity | Claudin-1 targeted therapies for fibrosis and cancer |
| Website | alentis.ch |
Medicines authorised in Switzerland
No medicine authorisation
Alentis Therapeutics AG is not recorded as an authorisation holder for human medicines with Swissmedic. That is normal for device manufacturers, contract manufacturers, wholesalers, laboratories and consultancies.
Biotechnological products, blood products, vaccines, cell and gene therapies and allergens.
Frequently asked questions
How many medicines does Alentis Therapeutics AG have authorised in Switzerland?
Alentis Therapeutics AG holds no Swissmedic authorisations for human medicines (as of 1 September 2026). The company is listed here as a Biotech business.
Where is Alentis Therapeutics AG based?
The Swiss location recorded for Alentis Therapeutics AG is Basel, Basel-Stadt.
Is Alentis Therapeutics AG a Swissmedic authorisation holder?
No. Alentis Therapeutics AG does not appear as an authorisation holder in the Swissmedic list. To reach the Swiss market, a foreign manufacturer needs an authorisation holder domiciled or represented in Switzerland.